Social economic costs and health‐related quality of life in patients with degenerative cerebellar ataxia in Spain

To determine the economic burden (direct and indirect costs), as well as health‐related quality of life (HRQOL) in patients diagnosed with spinocerebellar ataxia (SCA) in Spain. A cross‐sectional study was carried out on 84 patients with SCA from the Spanish Ataxia Federation (FEDAES) during 2004. A retrospective assessment of the use of resources was obtained through questionnaires filled out by the patients or the patient's caregivers. The approach used was the cost‐of‐illness study based on a societal perspective. To assess HRQOL in patients with SCA, they were asked to fill out the EQ‐5D generic questionnaire. The mean annual cost per patient with SCA was €18,776. The most important categories of costs were informal care, early retirement (permanent disability), medications, and orthopaedic devises. The mean EQ‐5D index score was 0.48 (0.38 for high and 0.58 for low severity patients) and the mean EQ‐5D VAS score was 48 (43 for high and 52 for low severity patients). Considerations of the costs related to caregivers due to the patients' disabilities, as well as the high indirect costs resulting from permanent disabilities in patients with SCA, should become a priority for health authorities. Furthermore, the patients' quality of life, as determined by the EQ‐5D questionnaire, was very low and substantially influenced by the degree of severity of SCA. © 2007 Movement Disorder Society

[1]  W Max,et al.  The lifetime cost of injury. , 1990, Inquiry : a journal of medical care organization, provision and financing.

[2]  F. Antoñanzas,et al.  [The cost of type 2 diabetes in Spain: the CODE-2 study]. , 2002, Gaceta sanitaria.

[3]  S. Perlman Symptomatic and Disease-Modifying Therapy for the Progressive Ataxias , 2004, The neurologist.

[4]  M. Drummond,et al.  Economics and Schizophrenia: The Real Cost , 1994, British Journal of Psychiatry.

[5]  M A Koopmanschap,et al.  The friction cost method for measuring indirect costs of disease. , 1995, Journal of health economics.

[6]  P. S. Aguilar,et al.  PIN18 DETERMINANTS OF HEALTH CARE COSTS IN AMBULATORY PATIENTS LIVING WITH HIV/AIDS , 2005 .

[7]  R. D’Ambrosio,et al.  Disability and quality of life in hereditary ataxias: a self-administered postal questionnaire. , 1987, International disability studies.

[8]  D McDaid,et al.  Estimating the costs of informal care for people with Alzheimer's disease: methodological and practical challenges , 2001, International journal of geriatric psychiatry.

[9]  P. Aguilar,et al.  Los costes socioeconómicos de la diabetes mellitus , 2002 .

[10]  J. L. Bastida,et al.  CV2 THE ECONOMIC BURDEN OF STROKE IN SPAIN , 2003 .

[11]  X. Badia,et al.  [The Spanish version of EuroQol: a description and its applications. European Quality of Life scale]. , 1999, Medicina clinica.

[12]  R. Brooks EuroQol: the current state of play. , 1996, Health policy.

[13]  E. Mishan Evaluation of Life and Limb: A Theoretical Approach , 1971, Journal of Political Economy.

[14]  O. Combarros,et al.  [Hereditary ataxias and paraplegias: a clinicogenetic review]. , 2002, Neurologia.

[15]  Ron Goeree,et al.  The Economic Burden of Schizophrenia in Canada , 1999, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  B. Jönsson,et al.  Diabetes: the cost of illness in Sweden , 1998, Journal of internal medicine.

[17]  O. Combarros,et al.  Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. , 1991, Brain : a journal of neurology.

[18]  J. Robinson,et al.  Philosophical origins of the economic valuation of life. , 1986, The Milbank quarterly.

[19]  X. Badia,et al.  Using the EuroQol 5-D in the Catalan General Population: Feasibility and Construct Validity , 1998, Quality of Life Research.

[20]  M. Tafalla,et al.  El coste de la diabetes tipo 2 en España. El estudio CODE-2 , 2002 .

[21]  P. Dolan,et al.  Modeling valuations for EuroQol health states. , 1997, Medical care.

[22]  P. Serrano Aguilar,et al.  [The social and economic cost of diabetes mellitus]. , 2002, Atencion primaria.

[23]  L. Perestelo-Pérez,et al.  Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain , 2006, Neurology.

[24]  J. Hobart,et al.  Coordinating outcomes measurement in ataxia research: Do some widely used generic rating scales tick the boxes? , 2006, Movement disorders : official journal of the Movement Disorder Society.

[25]  L. Perestelo-Pérez,et al.  Social economic costs and health-related quality of life in patients with amyotrophic lateral sclerosis in Spain , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[26]  T. Hodgson,et al.  Cost-of-illness methodology: a guide to current practices and procedures. , 1982, The Milbank Memorial Fund quarterly. Health and society.

[27]  J. López‐Bastida,et al.  [Socioeconomic costs of cardiovascular disease and cancer in the Canary Islands (Spain) in 1998]. , 2003, Gaceta sanitaria.

[28]  P. Serrano-Aguilar,et al.  Los costes socioeconómicos de las enfermedades cardiovasculares y del cáncer en las Islas Canarias en 1998 , 2003 .

[29]  J. L. Bastida,et al.  The economic costs of traffic accidents in Spain. , 2004, The Journal of trauma.